Identification and validation of key extracellular proteins as the potential biomarkers in diabetic nephropathy

被引:1
|
作者
Pan, Wei [1 ]
Zhang, Qiankun [2 ]
Gong, Xiaohua [1 ]
Wu, Wenjun [1 ]
Zhou, Qi [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Wenzhou 325015, Peoples R China
[2] Zhejiang Univ, Wenzhou Med Univ, Lishui Cent Hosp, Dept Nephrol,Affiliated Hosp 5,Lishui Hosp, Lishui 323000, Peoples R China
关键词
TNF; Extracellular matrix; Dendritic cell; Diabetic nephropathy; Glycosaminoglycan degradation; KIDNEY-DISEASE; HIGH GLUCOSE; EXPRESSION; MODEL; CELL; TNF;
D O I
10.1186/s40001-024-02120-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective Accumulation of extracellular matrix (ECM) proteins in the glomerular mesangial region is a typical hallmark of diabetic nephropathy (DN). However, the molecular mechanism underlying ECM accumulation in the mesangium of DN patients remains unclear. The present study aims to establish a connection between extracellular proteins and DN with the goal of identifying potential biomarkers for this condition. Methods Differentially expressed genes (DEGs) between DN kidney tissue and healthy kidney tissue were analyzed using the public data GSE166239. Two gene lists encoding extracellular proteins were then utilized to identify extracellular protein-differentially expressed genes (EP-DEGs). Functional enrichment analyses, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, were performed on these EP-DEGs. A protein-protein interaction (PPI) network was established to identify key EP-DEGs. Furthermore, the diagnostic ability, immune cell infiltration, and clinical relevance of these EP-DEGs were investigated. Immunohistochemistry (IHC) staining of paraffin-embedded renal tissues was performed to validate the accuracy of the bioinformatic results. Results A total of 1204 DEGs were identified, from which 162 EP-DEGs were further characterized by overlapping with extracellular protein gene lists. From the PPI network analysis, five EP-DEGs (e.g., TNF, COL1A1, FN1, MMP9, and TGFB1) were identified as candidate biomarkers. TNF, COL1A1, and MMP9 had a high diagnostic accuracy for DN. Assessment of immune cell infiltration revealed that the expression of TNF was positively associated with resting dendritic cells (DCs) (r = 0.85, P < 0.001) and M1 macrophages (r = 0.62, P < 0.05), whereas negatively associated with regulatory T cells (r = - 0.62, P < 0.05). Nephroseq v5 analysis demonstrated a negative correlation between the estimated glomerular filtration rate (eGFR) and TNF expression (r = - 0.730, P = 0.025). Gene set enrichment analysis (GSEA) revealed significant enrichment of glycosaminoglycan (GAG) degradation in the high-TNF subgroup. IHC staining of renal tissues confirmed significantly elevated TNF-a expression and decreased hyaluronic acid (HA) levels in the DN group compared to controls (both P < 0.05), with a negative correlation observed between TNF-a and HA (r = - 0.691, P = 0.026). Conclusion Our findings suggest that TNF may play a pivotal role in the progress of DN by driving ECM accumulation, and this process might involve GAG degradation pathway activation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Identification of key biomarkers in diabetic nephropathy via bioinformatic analysis
    Zeng, Mengru
    Liu, Jialu
    Yang, Wenxia
    Zhang, Shumin
    Liu, Fuyou
    Dong, Zheng
    Peng, Youming
    Sun, Lin
    Xiao, Li
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (05) : 8676 - 8688
  • [2] Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy
    Hu, C.
    Sun, L.
    Xiao, L.
    Han, Y.
    Fu, X.
    Xiong, X.
    Xu, X.
    Liu, Y.
    Yang, S.
    Liu, F.
    Kanwar, Y. S.
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (24) : 2858 - 2870
  • [3] Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease
    Yu, Wei
    Wang, Ting
    Wu, Feng
    Zhang, Yiding
    Shang, Jin
    Zhao, Zhanzheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [4] Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy
    Ming, Jie
    Sana, Si Ri Gu Leng
    Deng, Xijin
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [5] Integrated bioinformatics analysis reveals novel key biomarkers in diabetic nephropathy
    Joshi, Harish
    Vastrad, Basavaraj
    Joshi, Nidhi
    Vastrad, Chanabasayya
    SAGE OPEN MEDICINE, 2022, 10
  • [6] Early renal structural changes and potential biomarkers in diabetic nephropathy
    Liu, Hao
    Feng, Jianguo
    Tang, Liling
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [7] Urinary exosomes: Potential biomarkers for diabetic nephropathy
    Sinha, Nisha
    Kumar, Vivek
    Puri, Veena
    Nada, Ritambhra
    Rastogi, Ashu
    Jha, Vivekanand
    Puri, Sanjeev
    NEPHROLOGY, 2020, 25 (12) : 881 - 887
  • [8] Liraglutide suppresses production of extracellular matrix proteins and ameliorates renal injury of diabetic nephropathy by enhancing Wnt/β-catenin signaling
    Huang, Linjing
    Lin, Tingting
    Shi, Meizhen
    Chen, Xiuqing
    Wu, Peiwen
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2020, 319 (03) : F458 - F468
  • [9] Identification and clinical validation of key genes as the potential biomarkers in colorectal adenoma
    Wang, Bangting
    Zhang, Jiting
    Wang, Xin
    Zhao, Lili
    Wang, Yan
    Fan, Zhining
    Liu, Li
    Gao, Wenqing
    BMC CANCER, 2023, 23 (01)
  • [10] Identification of key genes and pathways in diabetic nephropathy by bioinformatics analysis
    Geng, Xiao-dong
    Wang, Wei-wei
    Feng, Zhe
    Liu, Ran
    Cheng, Xiao-long
    Shen, Wan-jun
    Dong, Zhe-yi
    Cai, Guang-yan
    Chen, Xiang-mei
    Hong, Quan
    Wu, Di
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (04) : 972 - 984